ARCHIVES

DeLap: Seven Years In industry Provided View Of Pressures On Drug Developers

This article is from The Cancer Letter archive.

Vol. 22 No. 31 | August 2, 1996

Download PDF Visit The Full Archive

Related Articles

Avastin doubles progression-free survival in metastatic disease.

May 27, 2005

Guidelines Proposed For Control Grants

January 25, 1980

Program Announcement On Effects Of Low Dose Radiation

October 2, 1981

NIH Eyes FCRC For Intramural Space As Contract Recompetition Planning Nears

May 23, 1980

In Brief: Money Bill Delay Seen Until After Election ACCC Meeting Planned On Community Programs

September 15, 1978

HEW Ruling Limits Distribution Of Chemicals From Repository To Contractors, Government

May 7, 1976